Ophthalmology Education and CME

  • Top Picks
    • Patient Profiles on Anti-Infectives
    • The Importance of NSAIDS After Cataract Surgery: Considerations on Penetration, Efficacy, Pharmacy Fills and Callbacks
    • MicroPulse Laser Therapy in the Management of DME
    • Video Innovator Series

Select a Topic

  • FILTER BY:
Patient profiles on anti-infectives

Patient Profiles on Anti-Infectives

This activity is sponsored by Bausch + Lomb.

June 30, 2016

Learn as leading experts share their perspective on treating patients with bacterial conjunctivitis and herpetic keratitis….

go to activity»
The Importance of NSAIDS After Cataract Surgery: Considerations on Penetration, Efficacy, Pharmacy Fills and Callbacks

The goal of cataract surgery is to improve vision for patients, so ophthalmologists need more than just a quality IOL and the latest surgical tools on hand. For patients…

go to activity»
Scott
CME

Key Components in the Design and Execution of a Successful Clinical Trial

This activity is supported by educational grants from Allergan, Inc.; Genentech, Inc.; and Regeneron Pharmaceuticals, Inc.

Expiration Date: 3/25/2017
Credit Type(s): CME | Credit: 0.25

The advent of intravitreal therapies to treat retinal diseases has revolutionized the management of retinal pathology. Reviewing the major trials and their subsequent…

go to activity»
Flynn
CME

Clinical Trials in Diabetic Retinopathy

This activity is supported by educational grants from Allergan, Inc.; Genentech, Inc.; and Regeneron Pharmaceuticals, Inc.

Expiration Date: 3/25/2017
Credit Type(s): CME | Credit: 0.5

The advent of intravitreal therapies to treat retinal diseases has revolutionized the management of retinal pathology. Reviewing the major trials and their subsequent…

go to activity»
Singh
CME

Comparative Treatment Trials for Wet AMD: A Comprehensive Review

This activity is supported by educational grants from Allergan, Inc.; Genentech, Inc.; and Regeneron Pharmaceuticals, Inc.

Expiration Date: 3/25/2017
Credit Type(s): CME | Credit: 0.5

The advent of intravitreal therapies to treat retinal diseases has revolutionized the management of retinal pathology. Reviewing the major trials and their subsequent…

go to activity»
Boyer
CME

Conducting Macular Clinical Trials in a Private Practice Environment

This activity is supported by educational grants from Allergan, Inc.; Genentech, Inc.; and Regeneron Pharmaceuticals, Inc.

Expiration Date: 3/25/2017
Credit Type(s): CME | Credit: 0.25

The advent of intravitreal therapies to treat retinal diseases has revolutionized the management of retinal pathology. Reviewing the major trials and their subsequent…

go to activity»
	 J094 Activity Type	 Article/E-publication Activity Title	 Cataract360 – Fundamentals, Techniques, & Technology: Volume 1, Number 1
CME

Cataract360 - Fundamentals, Techniques, & Technology: Volume 1, Number 1

This activity is supported by educational grants from Abbott Medical Optics, Alcon Research, Ltd., and Bausch + Lomb.

Expiration Date: 5/25/2017
Credit Type(s): CME | Credit: 1.25

Successful cataract surgery is a multifactorial process that relies on numerous interconnected assessment, planning, and execution procedures. Phacodynamics, the effects…

go to activity»
MicroPulse

MicroPulse Laser Therapy in the Management of DME

This promotional educational activity is presented by IRIDEX.

April 4, 2016

Watch as Allen C. Ho, MD; Robert L. Avery, MD; Lawrence S. Morse, MD, PhD; Elias Reichel, MD present topics focusing on effective laser treatment in the management of…

go to activity»
waheed
CME

Imaging Modalities in Clinical Trials

This activity is supported by educational grants from Allergan, Inc.; Genentech, Inc.; and Regeneron Pharmaceuticals, Inc.

Expiration Date: 3/25/2017
Credit Type(s): CME | Credit: 0.5

The advent of intravitreal therapies to treat retinal diseases has revolutionized the management of retinal pathology. Reviewing the major trials and their subsequent…

go to activity»
Ip
CME

Central and Branch Retinal Vein Occlusion Clinical Trials: A Comprehensive Review

This activity is supported by educational grants from Allergan, Inc.; Genentech, Inc.; and Regeneron Pharmaceuticals, Inc.

Expiration Date: 3/25/2017
Credit Type(s): CME | Credit: 0.5

The advent of intravitreal therapies to treat retinal diseases has revolutionized the management of retinal pathology. Reviewing the major trials and their subsequent…

go to activity»
Moshfeghi
CME

Wet Macular Degeneration: A Review of Pivotal Clinical Trials

This activity is supported by educational grants from Allergan, Inc.; Genentech, Inc.; and Regeneron Pharmaceuticals, Inc.

Expiration Date: 3/25/2017
Credit Type(s): CME | Credit: 0.5

The advent of intravitreal therapies to treat retinal diseases has revolutionized the management of retinal pathology. Reviewing the major trials and their subsequent…

go to activity»
Video Innovator Series

Video Innovator Series

This promotional content is produced by SLACK Incorporated and sponsored by Alcon Laboratories, Inc.

March 22, 2016

Experts share their perspective on treating pain and inflammation associated with cataract surgery….

go to activity»
Patient profiles on anti-infectives

Patient Profiles on Anti-Infectives

This activity is sponsored by Bausch + Lomb.

June 30, 2016

Learn as leading experts share their perspective on treating patients with bacterial conjunctivitis and herpetic keratitis….

go to activity»
	 J094 Activity Type	 Article/E-publication Activity Title	 Cataract360 – Fundamentals, Techniques, & Technology: Volume 1, Number 1
CME

Cataract360 - Fundamentals, Techniques, & Technology: Volume 1, Number 1

This activity is supported by educational grants from Abbott Medical Optics, Alcon Research, Ltd., and Bausch + Lomb.

Expiration Date: 5/25/2017
Credit Type(s): CME | Credit: 1.25

Successful cataract surgery is a multifactorial process that relies on numerous interconnected assessment, planning, and execution procedures. Phacodynamics, the effects…

go to activity»
The Importance of NSAIDS After Cataract Surgery: Considerations on Penetration, Efficacy, Pharmacy Fills and Callbacks

The goal of cataract surgery is to improve vision for patients, so ophthalmologists need more than just a quality IOL and the latest surgical tools on hand. For patients…

go to activity»
MicroPulse

MicroPulse Laser Therapy in the Management of DME

This promotional educational activity is presented by IRIDEX.

April 4, 2016

Watch as Allen C. Ho, MD; Robert L. Avery, MD; Lawrence S. Morse, MD, PhD; Elias Reichel, MD present topics focusing on effective laser treatment in the management of…

go to activity»
Scott
CME

Key Components in the Design and Execution of a Successful Clinical Trial

This activity is supported by educational grants from Allergan, Inc.; Genentech, Inc.; and Regeneron Pharmaceuticals, Inc.

Expiration Date: 3/25/2017
Credit Type(s): CME | Credit: 0.25

The advent of intravitreal therapies to treat retinal diseases has revolutionized the management of retinal pathology. Reviewing the major trials and their subsequent…

go to activity»
waheed
CME

Imaging Modalities in Clinical Trials

This activity is supported by educational grants from Allergan, Inc.; Genentech, Inc.; and Regeneron Pharmaceuticals, Inc.

Expiration Date: 3/25/2017
Credit Type(s): CME | Credit: 0.5

The advent of intravitreal therapies to treat retinal diseases has revolutionized the management of retinal pathology. Reviewing the major trials and their subsequent…

go to activity»
Flynn
CME

Clinical Trials in Diabetic Retinopathy

This activity is supported by educational grants from Allergan, Inc.; Genentech, Inc.; and Regeneron Pharmaceuticals, Inc.

Expiration Date: 3/25/2017
Credit Type(s): CME | Credit: 0.5

The advent of intravitreal therapies to treat retinal diseases has revolutionized the management of retinal pathology. Reviewing the major trials and their subsequent…

go to activity»
Ip
CME

Central and Branch Retinal Vein Occlusion Clinical Trials: A Comprehensive Review

This activity is supported by educational grants from Allergan, Inc.; Genentech, Inc.; and Regeneron Pharmaceuticals, Inc.

Expiration Date: 3/25/2017
Credit Type(s): CME | Credit: 0.5

The advent of intravitreal therapies to treat retinal diseases has revolutionized the management of retinal pathology. Reviewing the major trials and their subsequent…

go to activity»
Singh
CME

Comparative Treatment Trials for Wet AMD: A Comprehensive Review

This activity is supported by educational grants from Allergan, Inc.; Genentech, Inc.; and Regeneron Pharmaceuticals, Inc.

Expiration Date: 3/25/2017
Credit Type(s): CME | Credit: 0.5

The advent of intravitreal therapies to treat retinal diseases has revolutionized the management of retinal pathology. Reviewing the major trials and their subsequent…

go to activity»
Moshfeghi
CME

Wet Macular Degeneration: A Review of Pivotal Clinical Trials

This activity is supported by educational grants from Allergan, Inc.; Genentech, Inc.; and Regeneron Pharmaceuticals, Inc.

Expiration Date: 3/25/2017
Credit Type(s): CME | Credit: 0.5

The advent of intravitreal therapies to treat retinal diseases has revolutionized the management of retinal pathology. Reviewing the major trials and their subsequent…

go to activity»
Boyer
CME

Conducting Macular Clinical Trials in a Private Practice Environment

This activity is supported by educational grants from Allergan, Inc.; Genentech, Inc.; and Regeneron Pharmaceuticals, Inc.

Expiration Date: 3/25/2017
Credit Type(s): CME | Credit: 0.25

The advent of intravitreal therapies to treat retinal diseases has revolutionized the management of retinal pathology. Reviewing the major trials and their subsequent…

go to activity»
Video Innovator Series

Video Innovator Series

This promotional content is produced by SLACK Incorporated and sponsored by Alcon Laboratories, Inc.

March 22, 2016

Experts share their perspective on treating pain and inflammation associated with cataract surgery….

go to activity»
J899 Cover Image
CME

Emerging Options for Day-in and Day-out IOP Control

This activity is supported by an educational grant from Bausch + Lomb.

Expiration Date: 3/29/2017
Credit Type(s): CME | Credit: 1

Unfortunately, even with appropriate use of currently available medications, many people with glaucoma will still experience vision loss. Intraocular pressure (IOP) is…

go to activity»
New Treatment Paradigms for Diabetic Retinopathy: Current Status and Applications for Practice
CME

New Treatment Paradigms for Diabetic Retinopathy: Current Status and Applications for Practice

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 3/10/2017
Credit Type(s): CME | Credit: 1

Despite a number of effective treatment options, diabetic eye disease is a leading cause of vision loss in the United States, in part because many patients are not…

go to activity»
J936
CME

Early to Late Age-related Macular Degeneration: Optimizing Assessment and Management

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 3/8/2017
Credit Type(s): CME | Credit: 1

Age-related macular degeneration (AMD) is a common eye condition and a leading cause of vision loss among people aged 50 years and older. Diagnosing AMD involves a…

go to activity»
J916 Cover
CME

Redefining the Role of Photodynamic Therapy in Neovascular Age-related Macular Degeneration

This activity is supported by an educational grant from Bausch + Lomb.

Expiration Date: 3/4/2017
Credit Type(s): CME | Credit: 1

Photodynamic therapy (PDT), with use of verteporfin as a photosensitizer, is one of the few therapies that has been shown to effectively slow the progression of the…

go to activity»
J930
CMEVIDEO

Current Insights: Applying New Data to Optimize Treatment of Diabetic Retinal Disease

This activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc.

Expiration Date: 3/3/2017
Credit Type(s): CME | Credit: 1

Intravitreal therapy with anti-VEGF agents has rapidly become the new standard of care in diabetic macular edema (DME), and is increasingly recognized as an effective…

go to activity»
j904
CME

Optimizing Ocular Surgery Outcomes with Topical Therapy

This activity is supported by an educational grant from Bausch + Lomb.

Expiration Date: 3/13/2017
Credit Type(s): CME | Credit: 1

Ocular pain and inflammation are common following surgery and may increase the risk of complications, such as cystoid macular edema (CME) and endophthalmitis. However…

go to activity»
Preserving the Ocular Surface: Practice Pearls That Go Beyond Just Scratching the Surface
CME

Preserving the Ocular Surface: Practice Pearls That Go Beyond Just Scratching the Surface

This activity is supported by an educational grant from Alcon Research, LTD., Allergan, Inc., Bausch + Lomb, and Shire.

Expiration Date: 3/13/2017
Credit Type(s): CME | Credit: 1.25

Ocular surface disorders (OSDs) are chronic, progressive, multifactorial conditions with prevalence increasing with age, including dry eye disease (DED). The numerous…

go to activity»
J934_CoverImage
CME

Looking Beyond the Obvious: Pathophysiology and Emerging Therapies for Dry Eye

This activity is supported by an educational grant from Shire.

Expiration Date: 2/15/2017
Credit Type(s): CME | Credit: 1

Dry eye is one of the most common causes of ocular surface disease (OSD) and is estimated to increase with the aging population. Its pathology is multifactorial…

go to activity»
Clarifying the Role of Novel and Emerging Treatments for Diabetic Retinopathy and Related Eye Disorders
CMECOPE

Clarifying the Role of Novel and Emerging Treatments for Diabetic Retinopathy and Related Eye Disorders

This activity is supported by an educational grant from Genentech, Inc.

January 29, 2016

Diabetic retinopathy (DR) causes 10,000 new cases of blindness every year in the United States. The severity of DR depends on several factors: glycemic control, blood…

go to activity»
Targeting steroid responsive inflammatory ocular conditions with a risk of infection
VIDEO

Targeting Steroid-Responsive Inflammatory Ocular Conditions With a Risk of Bacterial Infection

This activity is sponsored by Bausch + Lomb.

February 2, 2016

In this video series, learn from the experts how you can use..….

go to activity»
Retina Forums
CMEVIDEO

Best of Retina Forum: Focus on the Diabetic Eye

This activity is supported by educational grants from Allergan, Inc. and Regeneron Pharmaceuticals, Inc.

Expiration Date: 11/30/2016
Credit Type(s): CME | Credit: 2

The management of diabetic eye disease has undergone significant changes over the last 18 months. Two steroid implants have been approved for the management of diabetic…

go to activity»
Webinar 2 Cover
CMECOPE

Surfacing on the Web: Pre-, Peri- and Postoperative Practices: Managing the Ocular Surface

This activity is supported by an educational grant from Allergan, Inc.

Expiration Date: 12/28/2016
Credit Type(s): CME / COPE | Credit: 1

Dry eye can be a debilitating disease, both in terms of patients’ visual acuity as well as their quality of life. The varying etiologies of dry eye in different patient…

go to activity»
Taming the Difficult Diabetic Eye: Examining New Options for Treatment
CMEVIDEO

Taming the Difficult Diabetic Eye: Examining New Options for Treatment

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 12/14/2016
Credit Type(s): CME | Credit: 1

Proliferative diabetic retinopathy has long been one of the most challenging ocular conditions, as damage can be asymptomatic and often starts in the peripheral retina…

go to activity»
Using Treatment as Prevention: New and Emerging Options for Miosis, Postoperative Pain, and Inflammation
CMEVIDEO

Using Treatment as Prevention: New and Emerging Options for Miosis, Postoperative Pain, and Inflammation

This activity is supported by an educational grant from Omeros Corporation.

Expiration Date: 12/7/2016
Credit Type(s): CME | Credit: 1

Patients expect optimal vision immediately after cataract surgery, especially patients who have had premium IOLs implanted. Achieving optimal outcomes is driven by…

go to activity»
J155
CMEVIDEO

Early to Advanced AMD: Defining the Importance of Prompt Diagnosis and Treatment

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 1/29/2017
Credit Type(s): CME | Credit: 1.5

Management of the geographic atrophy seen in late-stage dry age-related macular degeneration (AMD) poses several challenges. Scientific understanding of geographic…

go to activity»
Webinar 1 Cover
CMECOPE

Surfacing on the Web: Dry Eye in Special Populations

This activity is supported by an educational grant from Allergan, Inc.

Expiration Date: 12/28/2016
Credit Type(s): CME / COPE | Credit: 1

Dry eye can be a debilitating disease, both in terms of patients’ visual acuity as well as their quality of life. The varying etiologies of dry eye in different patient…

go to activity»
J721
CMEVIDEO

Achieving Premium Results with Premium IOL Cataract Surgery: Managing Patients’ Expectations and Improving Outcomes

This activity is supported by an educational grant from Bausch + Lomb.

Expiration Date: 12/4/2016
Credit Type(s): CME | Credit: 1

Presbyopic intraocular lenses (IOLs) appear to be making inroads in cataract surgeons’ practices. The counterpart to presbyopic lenses in the premium channel, toric…

go to activity»
Healio - Ophtalmology
CME

Clinical Consensus: Managing Dry Eye and Ocular Surface Disorders

This activity is supported by an educational grant from Allergan, Inc.

Expiration Date: 11/1/2016
Credit Type(s): CME | Credit: 1.5

Managing the ocular surface is critical for a patient’s vision and quality of life. For patients undergoing cataract or refractive surgery, a compromised ocular…

go to activity»
The three pillars of IOL performance

The Three Pillars of IOL Performance: BioMaterial, BioMechanics, BioOptics

This activity is produced by SLACK Incorporated and sponsored by Alcon Laboratories, Inc.

October 21, 2015

Cataract surgeons have used the IOL platforms they believe to provide the best possible visual outcomes for their patients. Although IOLs are typically reliable and…

go to activity»
What Postoperative Ocular Steroid Are You Using?

What Postoperative Ocular Steroid Are You Using?

This activity is sponsored by Bausch + Lomb.

September 29, 2015

Watch as Marguerite McDonald, MD; John D. Sheppard, MD; and Rajesh K. Rajpal, MD discuss their experience with a postoperative ocular steroid….

go to activity»
Integrated Solutions

Watch as Victor H. Gonzalez, MD; Robin D. Ross, MD; and Sunil K. Srivastava, MD present surgical pearls….

go to activity»
In Focus: Advances in AMD – Current, Emerging, and Future Strategies for the Management of Dry AMD
CME

In Focus: Advances in AMD – Current, Emerging, and Future Strategies for the Management of Dry AMD

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 10/30/2017
Credit Type(s): CME | Credit: 0.5

Dry age-related macular degeneration has proven to be a challenging condition for clinicians, and no pharmaceutical options have been shown to be effective. Dry AMD is a…

go to activity»
Sadda
CME

In Focus: Advances in AMD – Managing Wet AMD in 2014 - What Do the Data Tell Us, and What Don’t They?

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 10/30/2017
Credit Type(s): CME | Credit: 0.5

A number of clinical trials have established the use of anti-VEGF therapy as first-line therapy in the management of wet age-related macular degeneration, and…

go to activity»
Hariprasad
CME

In Focus: Advances in AMD – Clinical Case: Starting therapy in a patient newly diagnosed with wet AMD

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 10/30/2017
Credit Type(s): CME | Credit: 0.25

Successful early treatment of wet age-related macular degeneration offers the best odds for maintaining visual acuity over time. In this activity, Seenu Hariprasad, MD…

go to activity»
boyer
CME

In Focus: Advances in AMD - Clinical Case: Long-term Management of Established Age-related Macular Degeneration

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 10/30/2017
Credit Type(s): CME | Credit: 0.25

Long-term management of wet age-related macular degeneration can be challenging, as medications and dosing schedules that had previously improved visual acuity may lose…

go to activity»
IN FOCUS: Advances in AMD - Strategies and Options in Managing Wet and Dry AMD
CME

IN FOCUS: Advances in AMD - Strategies and Options in Managing Wet and Dry AMD

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 10/27/2017
Credit Type(s): CME | Credit: 0.75

The damage associated with age-related macular degeneration begins before visual symptoms occur, making early diagnosis critical in achieving the best outcomes for…

go to activity»
Blephartis Management

Blepharitis Management: Current Thinking and Clinical Insights

This activity is sponsored by Bausch + Lomb.

July 25, 2014

Blepharitis Management: Current Thinking and Clinical Insights….

go to activity»
Diabetic Retinopathy
CME

Diabetic Retinopathy and Related Eye Disorders: New Developments in Diagnosis and Treatment

This activity is supported by an educational grant from Genentech, Inc.

September 4, 2015

This educational activity has been designed to apprise eye care specialists (including optometrists, ophthalmologists, and retina specialists) of breakthroughs in the…

go to activity»
J85B Activity Image
CECOPECME

Ocular Surface Diseases, Disorders, and Dysfunctions: Volume 1, Number 2

This activity is supported by an educational grant from Shire.

Expiration Date: 12/10/2016
Credit Type(s): COPE / CME | Credit: 1.25

Maintenance of the health of the ocular surface is complex due to the number of potential challenges, including dry eye disease, which can have a range of causes;…

go to activity»
J85A Activity Image
COPECME

Ocular Surface Diseases, Disorders, & Dysfunctions: Volume 1, Number 1

Expiration Date: 11/10/2016
Credit Type(s): CME / COPE | Credit: 1.25

Maintenance of the health of the ocular surface is complex due to the number of potential challenges, including dry eye disease, which can have a range of causes;…

go to activity»
Diabetic Retinopathy: The Importance of Early Screening, Referral, and Management
CME

Diabetic Retinopathy: The Importance of Early Screening, Referral, and Management

This activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc.

Expiration Date: 11/15/2016
Credit Type(s): CME | Credit: 1.5

Diabetic eye disease is one of the most common causes of vision loss in the United States. As the rates of diabetes increase, the number of affected patients will rise…

go to activity»
Avoiding “Loss of Chance”…
CME

Avoiding “Loss of Chance”… Improving the Screening, Treatment, and Referral of Patients with Diabetic Retinopathy

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 9/1/2016
Credit Type(s): CME | Credit: 1.25

Despite a number of effective treatment options, diabetic eye disease is a leading cause of vision loss in the United States, in part because many patients are not…

go to activity»
Diabetic Eye Cover Image
CME

Diabetic Eye 2015: New Concepts in Screening, Managing, and Referral

This activity is supported by an educational grant from Allergan, Inc.

Expiration Date: 8/10/2016
Credit Type(s): CME | Credit: 1.25

Despite a number of effective treatment options, diabetic eye disease is a leading cause of vision loss in the United States, in part because many patients are not…

go to activity»